Arca
Skip to content
Tools
Tools

-ium

Drugs with a permanently charged nitrogen (quaternary ammonium).

  • Drugs ending in -ium: 200
  • Approved somewhere: 59
  • With a US drug page: 46

What it means

Stem from WHO's stem book, 2024; description by Arca
Stem
-ium
Class
Drugs with a permanently charged nitrogen (quaternary ammonium)
Sub-stems
-curium, -onium
Most common targets
Muscle-type nicotinic acetylcholine receptor (11), CHRM3 (5), CHRM1 (4), ACHE (4), IMPA1 (2), GSK3A, GSK3B (2), Potassium (2), CHRM2 (2)

Drugs that carry it

Approved and clinical-stage drugs in ChEMBL whose names ending in -ium or one of its sub-stems, matched by spelling; those with a US drug page link to it.
Acts on
BretyliumApprovedSLC6A2Norepinephrine transporter substrate
ClidiniumApprovedCHRM3, CHRM1Muscarinic acetylcholine receptor M3 antagonist
DemecariumApprovedACHEAcetylcholinesterase inhibitor
HexocycliumApprovedCHRM3, CHRM1Muscarinic acetylcholine receptor M3 antagonist
Lithium carbonateApprovedIMPA1, GSK3A, GSK3BInositol-1(or 4)-monophosphatase 1 inhibitor
Potassium iodideApproved—Unknown
Potassium perchlorateApproved——
Potassium phosphate, monobasicApproved——
Selenium sulfideApproved—Unknown
Sodium bicarbonateApproved——
Sodium gluconateApproved——
Sodium iodideApproved——
Sodium monofluorophosphateApproved——
Sodium phosphate, monobasicApproved——
Sodium polystyrene sulfonateApprovedPotassiumPotassium sequestering agent
Sodium zirconium cyclosilicateApprovedPotassiumPotassium chelating agent
Technetium tc 99M sulfur colloidApproved—Diagnostic agent
Technetium tc 99M tilmanoceptApproved—Diagnostic
Technetium TC-99M labeled carbonApproved——
TrospiumApprovedCHRM3, CHRM2Muscarinic acetylcholine receptor M3 antagonist
HeliumPhase 3——
LithiumPhase 3——
Sodium ferric gluconate complexPhase 3—Supplement
Gallium nitratePhase 2Ribonucleoside-diphosphate reductase RR1, HydroxyapatiteRibonucleoside-diphosphate reductase RR1 inhibitor
Potassium gluconatePhase 1——
Potassium bicarbonateEarly phase 1——
Barium sulfate——Diagnostic agent
Hexafluorenium—ACHEAcetylcholinesterase inhibitor
Pentolinium—CHRNA3, CHRNB4Neuronal acetylcholine receptor; alpha3/beta4 antagonist
Technetium tc 99M depreotide——Diagnostic agent
Aluminium oxideApproved——
Gallium oxodotreotideApproved—Diagnostic agent
Lithium citrate anhydrousApprovedIMPA1, GSK3A, GSK3BInositol-1(or 4)-monophosphatase 1 inhibitor
Lutetium chlorideApproved—Diagnostic agent
Lutetium oxodotreotideApprovedSomatostatin receptorSomatostatin receptor binding agent
Magnesium carbonateApproved—Neutralises acid
Magnesium chloride anhydrousApproved——
Magnesium citrateApproved—Osmotic laxative
Magnesium hydroxideApproved—Saline laxative
Magnesium oxideApproved——
Magnesium sulfate anhydrousApproved—Unknown
PinaveriumApproved——
Potassium chlorideApproved—Supplement
Potassium citrate anhydrousApproved——
PrajmaliumApproved——
Radium dichlorideApproved—Radiotherapy agent
Rubidium chlorideApproved——
Samarium lexidronam pentasodiumApproved—Unknown
Sodium acetateApproved——
Sodium ascorbateApproved——
Sodium chlorideApproved——
Sodium citrateApproved——
Sodium feredetateApproved—Supplement
Sodium fluorideApproved——
Sodium phosphate, dibasic, anhydrousApproved—Radiopharmaceutical
Sodium salicylateApproved——
Sodium sulfate anhydrousApproved—Laxative
Strontium chlorideApproved—Unknown
Technetium pentetateApproved—Diagnostic agent
Technetium sestamibiApproved—Diagnostic agent
Titanium dioxideApproved——
Yttrium chlorideApproved—Diagnostic agent
Yttrium y 90 ibritumomab tiuxetanApprovedMS4A1B-lymphocyte antigen CD20 binding agent
Bifidobacterium spp.Phase 3—Probiotic
ChromiumPhase 3——
DequaliniumPhase 3—Unknown
EnisamiumPhase 3——
Hafnium oxidePhase 3——
Indium in 111 ibritumomab tiuxetanPhase 3——
MagnesiumPhase 3——
OpiumPhase 3——
PotassiumPhase 3——
Potassium nitratePhase 3——
RadiumPhase 3——
SamariumPhase 3——
SeleniumPhase 3——
Sodium alginatePhase 3——
Sodium dichloroacetatePhase 3Pyruvate dehydrogenase kinasePyruvate dehydrogenase kinase inhibitor
Sodium lactatePhase 3——
Sodium lauryl sulfatePhase 3——
StrontiumPhase 3——
Yttrium y 90 clivatuzumab tetraxetanPhase 3MUC5ACMucin-5AC binding agent
AlagebriumPhase 2——
AlbitiazoliumPhase 2——
AmeziniumPhase 2——
CetylpyridiniumPhase 2—Unknown
Gallium citratePhase 2——
Lutetium (LU177) rosopatamab tetraxetanPhase 2——
Lutetium lu 177 zadavotide guraxetanPhase 2——
Lutetium rofapitidexetanPhase 2——
NolpitantiumPhase 2——
Potassium hydroxidePhase 2——
Potassium magnesium citrate (4:1:2)Phase 2——
Potassium phosphate, dibasicPhase 2——
PrifiniumPhase 2——
PropagermaniumPhase 2——
Psyllium huskPhase 2——
RepagermaniumPhase 2——
Sodium benzoatePhase 2—Unknown
Sodium butyratePhase 2——
Sodium ferrous citratePhase 2——
Sodium nitratePhase 2——
Sodium phenylacetatePhase 2GlutamineGlutamine sequestering agent
Sodium propionatePhase 2——
Sodium succinatePhase 2——
Sodium tungstatePhase 2——
TimepidiumPhase 2——
YttriumPhase 2——
Yttrium y 90 epratuzumab tetraxetanPhase 2CD22CD22 inhibitor
Actinium dotatatePhase 1——
CesiumPhase 1——
Chromium picolinatePhase 1——
ExeporfiniumPhase 1——
Lutetium (LU177) lilotomab satetraxetanPhase 1——
Lutetium LU177 edotreotidePhase 1——
Lutetium PSMA-R2Phase 1——
Magnesium stearatePhase 1——
NeotetrazoliumPhase 1——
Potassium sodium hydrogen citrate anhydrousPhase 1——
PudexacianiniumPhase 1——
PyrviniumPhase 1—Unknown
Rhenium RE-186 obisbemedaPhase 1——
Sodium pentaboratePhase 1——
Sodium sulfidePhase 1——
Technetium mebrofeninPhase 1——
UtenpaniumPhase 1——
Potassium phosphate, unspecified formEarly phase 1——
TechnetiumEarly phase 1——
Aluminium nicotinate———
Bephenium———
Bephenium hydroxynaphthoate——Unknown
Cerium oxalate———
Fenpiverinium———
Indium chloride——Diagnostic agent
Indium in 111 capromab pendetide——Diagnostic agent
Indium oxyquinoline——Diagnostic agent
Indium pentetreotide——Diagnostic agent
Lapyrium——Unknown
Magnesium peroxide———
Potassium salicylate———
Potassium sulfate——Unknown
Rimazolium———
Rubidium——Diagnostic agent
Sodium chromate——Radiopharmaceutical
Sodium pertechnetate——Diagnostic agent
Sodium tartrate———
Technetium (99MTC) apcitide——Diagnostic agent
Technetium pyrophosphate——Diagnostic agent
Technetium succimer—A2MAlpha-2-macroglobulin binding agent
Technetium tc 99M albumin aggregated——Diagnostic agent
Technetium tc 99M arcitumomab——Diagnostic agent
Technetium tc 99M fanolesomab——Diagnostic
Technetium tc 99M nofetumomab merpentan——Diagnostic agent
Technetium tc 99M red blood cells——Diagnostic agent
Technetium TC-99M trofolastat chloride——Diagnostic
Thiazinamium———
Ytterbium pentetate—Radioactive metalsRadioactive metals chelating agent
Yttrium y 90 capromab pendetide—FOLH1Glutamate carboxypeptidase II binding agent
Yttrium y 90 epratuzumab—CD22CD22 binding agent
Yttrium y 90 labetuzumab—CEACAM5Carcinoembryonic antigen-related cell adhesion molecule 5 binding agent
Yttrium y 90 tacatuzumab tetraxetan—AFPAlpha-fetoprotein binding agent
AtracuriumApprovedMuscle-type nicotinic acetylcholine receptorMuscle-type nicotinic acetylcholine receptor antagonist
CisatracuriumPhase 3Muscle-type nicotinic acetylcholine receptorMuscle-type nicotinic acetylcholine receptor antagonist
MivacuriumPhase 2Muscle-type nicotinic acetylcholine receptorMuscle-type nicotinic acetylcholine receptor antagonist
Doxacurium—Muscle-type nicotinic acetylcholine receptorMuscle-type nicotinic acetylcholine receptor antagonist
GlycopyrroniumApprovedCHRM3, CHRM1, Muscarinic acetylcholine receptorMuscarinic acetylcholine receptor M3 antagonist
IsavuconazoniumApprovedLanosterol 14-alpha demethylaseLanosterol 14-alpha demethylase inhibitor
OxyphenoniumApprovedCHRM3, CHRM1Muscarinic acetylcholine receptor M3 antagonist
SofpironiumApprovedMuscarinic acetylcholine receptorMuscarinic acetylcholine receptor inhibitor
RocuroniumPhase 3Muscle-type nicotinic acetylcholine receptorMuscle-type nicotinic acetylcholine receptor antagonist
EdrophoniumPhase 1ACHEAcetylcholinesterase inhibitor
Ambenonium—ACHEAcetylcholinesterase inhibitor
Decamethonium—Muscle-type nicotinic acetylcholine receptorMuscle-type nicotinic acetylcholine receptor partial agonist
Pancuronium—Muscle-type nicotinic acetylcholine receptorMuscle-type nicotinic acetylcholine receptor antagonist
Pipecuronium—Muscle-type nicotinic acetylcholine receptorMuscle-type nicotinic acetylcholine receptor antagonist
Rapacuronium—Muscle-type nicotinic acetylcholine receptorMuscle-type nicotinic acetylcholine receptor antagonist
Vecuronium—Muscle-type nicotinic acetylcholine receptorMuscle-type nicotinic acetylcholine receptor antagonist
EmeproniumApproved——
Diammonium glycyrrhizinatePhase 3——
OtiloniumPhase 3——
SuxamethoniumPhase 3Muscle-type nicotinic acetylcholine receptorMuscle-type nicotinic acetylcholine receptor agonist
BenzoxoniumPhase 2——
BibenzoniumPhase 2——
DenatoniumPhase 2——
MeldoniumPhase 2——
SepantroniumPhase 2——
TibezoniumPhase 2——
TiemoniumPhase 2——
Zirconium (89ZR) girentuximab senvedoxamPhase 2——
Ammonium tetrathiomolybdatePhase 1——
BenzalkoniumPhase 1Cell membraneCell membrane disrupting agent
ToloniumPhase 1——
Zirconium ZR-89-desferrioxamine-IAB22M2CPhase 1——
Alcuronium—CHRM2Muscarinic acetylcholine receptor M2 positive allosteric modulator
Ambutonium——Unknown
Ammonium lactate——Unknown
Benzilonium———
Bevonium———
Fentonium———
Methiosulfonium———

Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.